Preparation and evaluation of celecoxib lyophilized orally disintegrating tablets with high bioavailability
European Journal of Pharmaceutics and Biopharmaceutics · 2025
DOI: 10.1016/j.ejpb.2025.114756 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2025. Verfasst von Shuai Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Pharmaceutical Science, Shandong 264000, China. Hauptthemen laut MEDLINE: Celecoxib. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Bohai Rim Advanced Research Institute for Drug Discovery.
Abstract (Originalsprache)
This study aimed to develop industrially feasible nano-lyophilized orally disintegrating tablets of celecoxib with high bioavailability and rapid onset of action. Nano-lyophilized orally disintegrating tablets were prepared using a media milling method combined with freeze-drying technology, in which the particle size of celecoxib was at the nanoscale. Single-factor experimental design and Box-Behnken statistical experimental design optimized the process and formulation. The optimized formulation contained 49.5 % celecoxib, 11.3 % PVP K30, 2.6 % SDS and 36.6 % mannitol. The tablets disintegrated within 5 s, with an average drug particle size of 351 nm after dispersion. The solubility of celecoxib increased significantly across all tested pH levels. In vitro release studies demonstrated that over 90 % of celecoxib was released from the tablets within 3 min. In vivo studies in rats and beagle dogs showed relative bioavailabilities of 155 % and 292 %, respectively, compared to Celebrex®, and tmax was reduced by 25.5 % and 33.5 %. The study successfully developed a nanotechnology-based lyophilized orally disintegrating tablet of celecoxib with enhanced bioavailability, offering a promising approach for low-dose NSAID formulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Pharmaceutical Science, Shandong 264000, China.
- Shanghai Jinbuhuan Lankao Pharmaceutical Co., Ltd., Kaifeng 475004 Henan, China.
- Bohai Rim Advanced Research Institute for Drug Discovery, Chinese Academy of Sciences, Yantai 264117 Shandong, China.
- Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Pharmaceutical Science, Shandong 264000, China. Electronic address: dfcheng@simmyt.ac.cn.
- Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Pharmaceutical Science, Shandong 264000, China. Electronic address: smkong@simmyt.ac.cn.
Förderung
- Bohai Rim Advanced Research Institute for Drug Discovery
Zitieren
APA
Sun, S., Wang, M., Chen, J., Ju, X., Zhang, F., He, M., Cheng, D., & Kong, S. (2025). Preparation and evaluation of celecoxib lyophilized orally disintegrating tablets with high bioavailability. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2025.114756
Vancouver
Sun S, Wang M, Chen J, Ju X, Zhang F, He M, et al. Preparation and evaluation of celecoxib lyophilized orally disintegrating tablets with high bioavailability. European Journal of Pharmaceutics and Biopharmaceutics. 2025. doi:10.1016/j.ejpb.2025.114756
BibTeX
@article{Sun2025,
author = {Sun, Shuai and Wang, Mengjun and Chen, Jin and Ju, Xiaoli and Zhang, Furong and He, Meilin and Cheng, Dongfang and Kong, Shumeng},
title = {Preparation and evaluation of celecoxib lyophilized orally disintegrating tablets with high bioavailability},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2025},
doi = {10.1016/j.ejpb.2025.114756}
}
EUVIMED